← Back to Search

Brief Acceptance and Commitment Therapy for Treatment

N/A
Waitlist Available
Led By Stephen A Maisto, PhD
Research Sponsored by Syracuse University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pain will be measured at baseline, 7-weeks post-baseline, 3 and 6-month follow-ups.
Awards & highlights

Study Summary

This trial will test a new treatment for people with HIV who also drink alcohol at hazardous levels. The treatment is based on Acceptance and Commitment Therapy, and it is designed to help with depression, anxiety, drug use, and ART adherence.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pain will be measured at baseline, 7-weeks post-baseline, 3 and 6-month follow-ups.
This trial's timeline: 3 weeks for screening, Varies for treatment, and pain will be measured at baseline, 7-weeks post-baseline, 3 and 6-month follow-ups. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in ART adherence from 3-months post-baseline to 6-months post-baseline
Change in ART adherence from 7-weeks post-treatment to 3-months post-baseline
Change in ART adherence from baseline to 6-months post-baseline
+5 more
Secondary outcome measures
Acceptance
Substance Use
Symptoms of Anxiety
+1 more
Other outcome measures
Alcohol-Related Problems
Chronic Pain
HIV Medication Adherence Self-Efficacy

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Brief Acceptance and Commitment TherapyExperimental Treatment1 Intervention
Participants randomized to the Acceptance and Commitment Therapy (ACT) arm will receive one, 1-hour intervention session followed by five weekly 30-45 minute intervention sessions delivered via telephone.
Group II: Brief Alcohol InterventionActive Control1 Intervention
Participants randomized to the Brief Alcohol Intervention (BI) will receive the following telephone-based sessions over the duration of six weeks: a 30-45 minute session of a brief alcohol intervention, a 5-10 minute booster call, a reminder phone call for the next intervention session, a 30-45 minute intervention session, a 5-10 minute booster, and a reminder phone call for the post-treatment appointment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Brief Acceptance and Commitment Therapy
2019
N/A
~50

Find a Location

Who is running the clinical trial?

Syracuse UniversityLead Sponsor
48 Previous Clinical Trials
117,525 Total Patients Enrolled
Stephen A Maisto, PhDPrincipal InvestigatorSyracuse University
1 Previous Clinical Trials
166 Total Patients Enrolled
Sarah E Woolf-King, PhDPrincipal InvestigatorSyracuse University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Brief Acceptance and Commitment Therapy for HIV-infected At-risk Drinkers
2019. "Brief Acceptance and Commitment Therapy for HIV-infected At-risk Drinkers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03974061.
~9 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top